Sepsis Test Developers Progress on Commercialization, Market Approvals of Rapid Tests During 2024
Article By Greg Cima / December 24, 2024
NEW YORK – In 2024, firms in the sepsis testing space made big moves to begin or expand the commercialization of tests that could help reduce the time-to-results, while many also secured funding to compete in an increasingly crowded space.
News
Outcome Capital Congratulates RealizedCare on the Acquisition by XRHealth
BOSTON– February 26, 2025 – Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, congratulates RealizedCare on the success of their company, and acquisition by XRHealth. Outcome Capital served as the exclusive strategic and financial advisor to RealizedCare. Through their digitally-powered care management triage platform and therapeutic solutions, RealizedCare […]
Read MoreResources
Outcome Capital Life Science Market Pulse, January 2025
Outcome Capital Life Science Market Pulse January 2025 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
